|
Oct 11
|
South Korean company Dong-A ST wins FDA approval for Stelara biosimilar
|
|
Oct 11
|
US FDA Approves Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®
|
|
Jan 5
|
FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara® (Ustekinumab)
|